Ipsen S.A.

IPN.PA | EURONEXT | 1 Obserwujący

€103.50

+1.27%

€1.30

Obserwuj

Overview Metrics Financials

Fair Price

YLP112.87

Undervalued by 93.5%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Ipsen S.A. is a French pharmaceutical company headquartered in Paris. The company specializes in research, development, manufacturing, and distribution of drugs primarily focused on the treatment of cancer, neurological disorders, and other specialized therapeutic areas. Its portfolio includes drugs for the treatment of various types of cancer, as well as drugs for the treatment of neurological disorders, endocrine disorders, and gastroenterological diseases. Ipsen is known for its innovative research and development of drug products aimed at improving the lives of patients with serious illnesses. The company has a global presence and is considered one of the leading players in the field of specialized pharmaceutical care. Shares of Ipsen S.A. are publicly traded on the Paris Stock Exchange.

Feed

There are no posts to show right now.

Ipsen S.A.

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?